Donaldson V H, Kleniewski J, Saito H, Sayed J K
J Clin Invest. 1977 Sep;60(3):571-83. doi: 10.1172/JCI108809.
Plasma from an individual with a hereditary deficiency of kininogens is deficient in kininogen antigens; heterozygous relatives are partially deficient in plasma kininogen antigens. In addition, plasma from the proband is partially deficient in functional and antigenic properties of a plasma prekallikrein, and the relatives heterozygous for kininogen deficiency are also partially deficient in the plasma prekallikrein. It is possible that the defects are both inherited and that the inheritance of a deficiency of prekallikrein is genetically linked to the inheritance of a deficiency of kininogen. Alternatively, it is possible that the deficiency of prekallikrein may be due to its hypercatabolism which could be a consequence of a deficiency of high molecular weight kininogen that may stabilize the prekallikrein in plasma. Evidence to support this possibility is presented by the fact that prekallikrein and high molecular weight kininogen apparently exist as a complex in normal plasma, because monospecific antiserum to kininogen removed both high molecular weight kininogen and prekallikrein from plasma, and vice versa. Moreover, prekallikrein was not adsorbed from kininogen-deficient plasma by antiserum to kininogen unless high molecular weight kininogen was first added to the plasma. Low molecular weight kininogen did not participate in these reactions.
患有遗传性激肽原缺乏症个体的血浆中缺乏激肽原抗原;杂合子亲属的血浆激肽原抗原部分缺乏。此外,先证者的血浆中血浆前激肽释放酶的功能和抗原特性部分缺乏,激肽原缺乏的杂合子亲属的血浆前激肽释放酶也部分缺乏。有可能这些缺陷都是遗传性的,并且前激肽释放酶缺乏的遗传与激肽原缺乏的遗传在基因上相关。或者,前激肽释放酶缺乏可能是由于其分解代谢亢进,这可能是血浆中高分子量激肽原缺乏的结果,而高分子量激肽原可能使血浆中的前激肽释放酶稳定。支持这种可能性的证据是,前激肽释放酶和高分子量激肽原在正常血浆中显然以复合物形式存在,因为针对激肽原的单特异性抗血清可从血浆中去除高分子量激肽原和前激肽释放酶,反之亦然。此外,除非先向血浆中添加高分子量激肽原,否则针对激肽原的抗血清不会从缺乏激肽原的血浆中吸附前激肽释放酶。低分子量激肽原不参与这些反应。